September 18, 2024
- The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial
- Risk factors for Charcot foot development in individuals with diabetes mellitus
- Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study
- Obstructive sleep apnoea and type 1 diabetes mellitus: A neglected relationship?
- Bilateral Foot Drop Caused by Acute-onset Neuropathy after Diabetic Ketoacidosis: Successful Management and Long-term Follow-up for Employment
- Ten years trajectories of estimated glomerular filtration rate (eGFR) in a multiethnic cohort of people with type 1 diabetes and preserved renal function
- Does autoimmune diseases increase the risk of frailty? A Mendelian randomization study
